229 related articles for article (PubMed ID: 28143426)
21. Cisplatin induces protective autophagy through activation of BECN1 in human bladder cancer cells.
Lin JF; Lin YC; Tsai TF; Chen HE; Chou KY; Hwang TI
Drug Des Devel Ther; 2017; 11():1517-1533. PubMed ID: 28553083
[TBL] [Abstract][Full Text] [Related]
22. Frondoside a suppressive effects on lung cancer survival, tumor growth, angiogenesis, invasion, and metastasis.
Attoub S; Arafat K; Gélaude A; Al Sultan MA; Bracke M; Collin P; Takahashi T; Adrian TE; De Wever O
PLoS One; 2013; 8(1):e53087. PubMed ID: 23308143
[TBL] [Abstract][Full Text] [Related]
23. Cell cycle arrest and apoptosis in TP53 subtypes of bladder carcinoma cell lines treated with cisplatin and gemcitabine.
da Silva GN; de Castro Marcondes JP; de Camargo EA; da Silva Passos Júnior GA; Sakamoto-Hojo ET; Salvadori DM
Exp Biol Med (Maywood); 2010 Jul; 235(7):814-24. PubMed ID: 20558835
[TBL] [Abstract][Full Text] [Related]
24. Immunomodulatory proteins FIP-gts and chloroquine induce caspase-independent cell death via autophagy for resensitizing cisplatin-resistant urothelial cancer cells.
Hsin IL; Wang SC; Li JR; Ciou TC; Wu CH; Wu HM; Ko JL
Phytomedicine; 2016 Dec; 23(13):1566-1573. PubMed ID: 27823620
[TBL] [Abstract][Full Text] [Related]
25. Butein and Frondoside-A Combination Exhibits Additive Anti-Cancer Effects on Tumor Cell Viability, Colony Growth, and Invasion and Synergism on Endothelial Cell Migration.
Sulaiman S; Arafat K; Al-Azawi AM; AlMarzooqi NA; Lootah SNAH; Attoub S
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008855
[TBL] [Abstract][Full Text] [Related]
26. Human bladder cancer cells undergo cisplatin-induced apoptosis that is associated with p53-dependent and p53-independent responses.
Konstantakou EG; Voutsinas GE; Karkoulis PK; Aravantinos G; Margaritis LH; Stravopodis DJ
Int J Oncol; 2009 Aug; 35(2):401-16. PubMed ID: 19578756
[TBL] [Abstract][Full Text] [Related]
27. Temsirolimus improves cytotoxic efficacy of cisplatin and gemcitabine against urinary bladder cancer cell lines.
Pinto-Leite R; Arantes-Rodrigues R; Ferreira R; Palmeira C; Colaço A; Moreira da Silva V; Oliveira P; Lara Santos L
Urol Oncol; 2014 Jan; 32(1):41.e11-22. PubMed ID: 24035472
[TBL] [Abstract][Full Text] [Related]
28. A Smac mimetic augments the response of urothelial cancer cells to gemcitabine and cisplatin.
Lee EK; Jinesh G G; Laing NM; Choi W; McConkey DJ; Kamat AM
Cancer Biol Ther; 2013 Sep; 14(9):812-22. PubMed ID: 23792592
[TBL] [Abstract][Full Text] [Related]
29. Gemcitabine and mitomycin induced autophagy regulates cancer stem cell pool in urothelial carcinoma cells.
Ojha R; Jha V; Singh SK
Biochim Biophys Acta; 2016 Feb; 1863(2):347-59. PubMed ID: 26658162
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of grade dependent autophagy in urothelial carcinoma increases cell death under nutritional limiting condition and potentiates the cytotoxicity of chemotherapeutic agent.
Ojha R; Singh SK; Bhattacharyya S; Dhanda RS; Rakha A; Mandal AK; Jha V
J Urol; 2014 Jun; 191(6):1889-98. PubMed ID: 24440234
[TBL] [Abstract][Full Text] [Related]
31. Cell cycle disturbances and apoptosis induced by topotecan and gemcitabine on human lung cancer cell lines.
Tolis C; Peters GJ; Ferreira CG; Pinedo HM; Giaccone G
Eur J Cancer; 1999 May; 35(5):796-807. PubMed ID: 10505042
[TBL] [Abstract][Full Text] [Related]
32. Chemoresistance is associated with increased cytoprotective autophagy and diminished apoptosis in bladder cancer cells treated with the BH3 mimetic (-)-Gossypol (AT-101).
Mani J; Vallo S; Rakel S; Antonietti P; Gessler F; Blaheta R; Bartsch G; Michaelis M; Cinatl J; Haferkamp A; Kögel D
BMC Cancer; 2015 Apr; 15():224. PubMed ID: 25885284
[TBL] [Abstract][Full Text] [Related]
33. Autophagy induction by low-dose cisplatin: the role of p53 in autophagy.
Cho KH; Park JH; Kwon KB; Lee YR; So HS; Lee KK; Lee SY; Moon SR; Yang SH
Oncol Rep; 2014 Jan; 31(1):248-54. PubMed ID: 24173208
[TBL] [Abstract][Full Text] [Related]
34. Pharmacokinetics in Mouse and Comparative Effects of Frondosides in Pancreatic Cancer.
Al Shemaili J; Parekh KA; Newman RA; Hellman B; Woodward C; Adem A; Collin P; Adrian TE
Mar Drugs; 2016 Jun; 14(6):. PubMed ID: 27322291
[TBL] [Abstract][Full Text] [Related]
35. Dicoumarol enhances doxorubicin-induced cytotoxicity in p53 wild-type urothelial cancer cells through p38 activation.
Matsui Y; Watanabe J; Ding S; Nishizawa K; Kajita Y; Ichioka K; Saito R; Kobayashi T; Ogawa O; Nishiyama H
BJU Int; 2010 Feb; 105(4):558-64. PubMed ID: 19583730
[TBL] [Abstract][Full Text] [Related]
36. Compensatory combination of romidepsin with gemcitabine and cisplatin to effectively and safely control urothelial carcinoma.
Pattarawat P; Hong T; Wallace S; Hu Y; Donnell R; Wang TH; Tsai CL; Wang J; Wang HR
Br J Cancer; 2020 Jul; 123(2):226-239. PubMed ID: 32390005
[TBL] [Abstract][Full Text] [Related]
37. Immunomodulatory properties of frondoside A, a major triterpene glycoside from the North Atlantic commercially harvested sea cucumber Cucumaria frondosa.
Aminin DL; Agafonova IG; Kalinin VI; Silchenko AS; Avilov SA; Stonik VA; Collin PD; Woodward C
J Med Food; 2008 Sep; 11(3):443-53. PubMed ID: 18800890
[TBL] [Abstract][Full Text] [Related]
38. MRE11A and SKP2 genes are associated with the increased cytotoxicity induced by the synergistic effects of cisplatin and gemcitabine in bladder cancer cells.
da Silva GN; de Camargo EA; Sávio AL; Salvadori DM
Mol Biol Rep; 2014 Jul; 41(7):4613-21. PubMed ID: 24652204
[TBL] [Abstract][Full Text] [Related]
39. Demethylating agent 5-aza-2'-deoxycytidine enhances susceptibility of bladder transitional cell carcinoma to Cisplatin.
Shang D; Liu Y; Matsui Y; Ito N; Nishiyama H; Kamoto T; Ogawa O
Urology; 2008 Jun; 71(6):1220-5. PubMed ID: 18538698
[TBL] [Abstract][Full Text] [Related]
40. Frondoside A inhibits breast cancer metastasis and antagonizes prostaglandin E receptors EP4 and EP2.
Ma X; Kundu N; Collin PD; Goloubeva O; Fulton AM
Breast Cancer Res Treat; 2012 Apr; 132(3):1001-8. PubMed ID: 21761157
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
